Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
Maria FusaroGiovanni Tripepi

Abstract

Long-term treatment with proton pump inhibitors (PPIs) is associated with an increased risk of fractures in the general population. PPIs are widely prescribed to dialysis patients but to date no study has specifically tested, by state-of-art statistical methods, the relationship between use of PPIs and fractures in this patient population. This study aimed to assess whether use of PPIs is associated with bone fractures (ie, hip fractures and fractures other than hip fractures) in a large international cohort of hemodialysis patients. We considered an observational prospective cohort of 27,097 hemodialysis patients from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Data analysis was performed by the Fine and Gray method, considering the competitive risk of mortality, as well as by a cause-specific hazards Cox model with death as a censoring event and matching patients according to the prescription time. Of 27,097 hemodialysis patients, 13,283 patients (49%) were on PPI treatment. Across the follow-up period (median, 19 months), 3.8 bone fractures × 100 person-years and 1.2 hip fractures × 100 person-years occurred. In multiple Cox models, considering the competitive risk of mortality, the incidence rate of bone (sub...Continue Reading

References

Aug 13, 2002·Current Pharmaceutical Design·Carlo Farina, S Gagliardi
Oct 9, 2002·Journal of the American Geriatrics Society·Cynthia L LeibsonL Joseph Melton
May 14, 2004·The New England Journal of Medicine·Robert R McLeanDouglas P Kiel
May 11, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Rosalie A M Dhonukshe-RuttenWija A van Staveren
Dec 28, 2006·JAMA : the Journal of the American Medical Association·Yu-Xiao YangDavid C Metz
Aug 13, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Laura E TargownikWilliam D Leslie
Jun 26, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Karen E HansenMartin M Shafer
May 25, 2011·The American Journal of Medicine·Elaine W YuDouglas C Bauer
Jun 14, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Maria FusaroUNKNOWN VItamin K Italian (VIKI) Dialysis Study Investigators
Jul 11, 2012·Therapeutic Advances in Gastroenterology·Joel J HeidelbaughPaul C Walker
Feb 19, 2013·PloS One·Stephen R Rotman, Tara F Bishop
May 15, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria FusaroMaurizio Gallieni
Aug 2, 2013·Kidney International·Francesca TentoriRonald L Pisoni
Aug 6, 2013·Nutrients·Sara CastiglioniJeanette A M Maier
Aug 26, 2014·Kidney International·Francesca TentoriRonald L Pisoni
Dec 17, 2014·Journal of the American Society of Nephrology : JASN·Sharon M MoeUNKNOWN Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators
Oct 9, 2015·Journal of the American Geriatrics Society·UNKNOWN By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel
Oct 16, 2015·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B ZhouJ Liu
Nov 4, 2015·JAMA : the Journal of the American Medical Association·Elizabeth D KantorEdward L Giovannucci
Nov 20, 2015·Journal of Clinical Pharmacology·Jeffrey H William, John Danziger
Mar 24, 2016·International Journal of Clinical Pharmacy·Kim S J LaoIan C K Wong
Jun 9, 2016·JAMA Internal Medicine·Maria FusaroMaurizio Gallieni
Sep 2, 2016·Therapeutic Advances in Gastroenterology·Anton PottegårdAnders B Lødrup
Apr 27, 2017·Medicine·Guangliang HaoXuecheng Cao
Dec 2, 2017·Journal of the American Society of Nephrology : JASN·Yusuke SakaguchiIkuto Masakane
Sep 29, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Chandan VangalaWolfgang C Winkelmayer

❮ Previous
Next ❯

Citations

Jul 31, 2020·Alimentary Pharmacology & Therapeutics·Christian LabenzKarel Kostev
Jul 28, 2020·Journal of Nephrology·Geoffroy Desbuissons, Lucile Mercadal
Mar 10, 2020·Clinical and Experimental Nephrology·Hiroo KawarazakiTakeshi Nakata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.